Oxford Finance, a specialty finance firm that provides senior debt to life sciences and healthcare services companies, closed an $8 million senior secured term loan with BiO2Medical. The funds are being used to support the company as it awaits FDA clearance for its Angel Catheter, and for the anticipated U.S. commercial launch of this product in mid-2016.

“Oxford is pleased to provide financial support to BiO2 Medical, a well-managed and innovative company,” said Christopher A. Herr, senior managing director at Oxford Finance. “The company has developed a differentiated product with distinct advantages over existing inferior vena cava filters currently available for the treatment of pulmonary embolisms.”

San Antonio, TX-based Bio2Medical, is currently focused on its flagship product, the Angel Catheter, a unique medical device designed to give physicians the control to provide temporary, prophylactic pulmonary embolism protection at the patient’s bedside.

Oxford Finance is a specialty finance firm providing senior secured loans to public and private life sciences and healthcare services companies worldwide.